SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis

The effect of sodium-glucose co-transporter-2 (SGLT-2) inhibitors on cardiovascular and renal outcomes has not been systematically reviewed across baseline kidney function groups. We conducted a systematic review and meta-analysis of randomized control trials (RCTs) with SGLT-2 inhibitors in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavrakanas, Thomas A., Tsoukas, Michael A., Brophy, James M., Sharma, Abhinav, Gariani, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517929/
https://www.ncbi.nlm.nih.gov/pubmed/37741858
http://dx.doi.org/10.1038/s41598-023-42989-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517929/
https://www.ncbi.nlm.nih.gov/pubmed/37741858
http://dx.doi.org/10.1038/s41598-023-42989-z

Ejemplares similares